 SAN DIEGO, June 3, 2021 PRNewswire -- Aethlon Medical, Inc. Nasdaq: AEMD, a medical device technology company focused on unmet needs in global health, today announced the publication of a pre-print manuscript highlighting two case studies of critically ill COVID-19 patients treated with the Aethlon Hemopurifier. Both patients were given access to Hemopurifier treatment through Emergency Use. 